Status:
TERMINATED
Efficacy of a Novel App-based Migraine Treatment Platform - a Pilot Study
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Ullevaal University Hospital
Conditions:
Migraine Disorders
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
This study evaluates biofeedback delivered through a smartphone as a treatment for migraine in adolescents. Three out of four participants will receive treatment as smartphone delivered biofeedback tr...
Detailed Description
Biofeedback is a behavioral treatment without known side effects. In biofeedback patients learn control over bodily reactions through feedback visualised on a screen. Typical bodily reactions that are...
Eligibility Criteria
Inclusion
- diagnosis of migraine with or without aura according to ICHD-3
- two to eight migraine attacks per month
- written informed consent signed by guardians, or by adolescent if age between 16-18 years.
Exclusion
- participant not speaking Norwegian
- reduced sensibility, hearing or vision to a degree that impairs proper use of the app
- serious psychiatric or neurologic disease and
- currently using migraine prophylaxis.
Key Trial Info
Start Date :
January 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 29 2020
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04106505
Start Date
January 11 2019
End Date
April 29 2020
Last Update
July 8 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo Universitetssykehuse, Ullevål
Oslo, Norway, 0450
2
St. Olavs Hospital
Trondheim, Norway, 7030